Site US00111 — New Brunswick, New Jersey

Site US00111 is a clinical research site located in New Brunswick, New Jersey, United States 08901.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Site US00111 has participated in 1 clinical trials.

Therapeutic areas: Overactive Bladder (OAB).

Sponsors: Astellas Pharma Global Development, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site US00111?

Site US00111 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site US00111 conducted?

Site US00111 has 1 clinical trials on record. Their work covers Overactive Bladder (OAB).

Is Site US00111 accredited by Crixeo Health?

Site US00111 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site US00111?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.